Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

Comment: AstraZeneca’s branded approach to YouTube

Company takes the path less travelled for pharma social media initiatives

- PMLiVE

Ipsen strengthens neurology efforts with Syntaxin purchase

French pharma firm also agrees research deal with Harvard

- PMLiVE

Simon Lowth steps down as AZ’s CFO

Joins natural gas firm BG Group in same role

- PMLiVE

Change the conversation in healthcare PR

How should healthcare public relations adapt to today’s integrated, social, multimedia, fast-paced, global environment?

- PMLiVE

New guidance equips consumer with clearer understanding of online behavioural advertising

The European Interactive Digital Advertising Alliance kicks off pan-European campaign with launches in UK and Ireland

- PMLiVE

Merck maintains lead in BACE inhibitors for Alzheimer’s

Positive results in phase Ib study in patients with Alzheimer’s disease

- PMLiVE

FDA clears first brain test to diagnose ADHD in children

NEBA system available as part of wider clinical assessment

- PMLiVE

Analysts question value of rumoured $20bn Roche bid for Alexion

Shares in orphan drug specialist slide back after earlier surge

National Institute for Health and Care Excellence NICE logo

Pfizer faces NICE rejection for cancer drug Bosulif

Draft guidance says drug is not cost-effective in chronic myeloid leukaemia

Sagent appoints Michael Fekete to board

Will support growth of injectables firm following initial public offering

- PMLiVE

Intellectual property threats in the BRIC markets

Compulsory licensing and other legal concerns for pharma in emerging markets

EISAI

Eisai’s epilepsy drug Zonegran wins Swiss approval

Swissmedic licences new monotherapy indication for the treatment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links